Reduce drug Research & Development cost and decrease time-to-market with a unique automation platform
Over the past 40 years, drug development costs have been increasing exponentially and the return on investment within pharmaceutical companies has come under pressure. Fast time-to-market is essential to be competitive and to serve today’s patients with the best possible medicines available.
A lot of time and money are spent on technology transfer and validation when moving from R&D to pre-clinical, to clinical trials, and finally to commercial production and vice versa.
Join us at Emerson Users Exchange Live EMEA, 29-31 March 2021 and Get Inspired by Applikon Biotechnology’s case study on how to improve tech transfer time and validation costs by using a common automation platform.
During the lifecycle of drug development, the technology, and data transfer from small scale laboratory applications to production, and vice versa is often challenging and time-consuming.
Applikon’s V-Control uses DeltaV as the automation platform for lab, clinical, and production scale solutions. By using an open architecture, V-Control gives users full access to the control logic and enables users to use all the DeltaV capabilities. The PK Controller can be used in modular skids for both single-use and stainless-steel solutions and can be easily integrated into existing DeltaV networks.
By using a common platform from R&D to production, users have recognized savings of up to 40% in re-work and validation costs and as a result new drugs can be introduced faster to market.
Join us at Emerson Users Exchange Live EMEA, 29-31 March 2021 and hear the whole story.
#EMRex #DeltaV #PK Controller #Applikon